A meta-analysis comparing observed 30-day all-cause mortality with the society of thoracic surgeons predicted risk of mortality in contemporary studies using valve academic research consortium definitions

International Journal of Cardiology

Volumn 168, Issue 2, 2013, Pages 1598-1602

  Takagi, Hisato ^a   Niwa, Masao ^a   Mizuno, Yusuke ^a   Yamamoto, Hirotaka ^a   Goto, Shin Nosuke ^a   Umemoto, Takuya ^a  

^a SHIZUOKA MEDICAL CENTER   (Japan)

Author keywords

Meta analysis; Mortality; Society of Thoracic Surgeons Predicted Risk of Mortality; Transcatheter aortic valve implantation; Valve Academic Research Consortium

Indexed keywords

AORTA STENOSIS; AORTA VALVE REPLACEMENT; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; DEATH; DISEASE SEVERITY; EFFECT SIZE; HIGH RISK PATIENT; HUMAN; INTERMETHOD COMPARISON; KIDNEY FAILURE; LETTER; META ANALYSIS; MORTALITY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT RESPONSE;

META-ANALYSIS; MORTALITY; SOCIETY OF THORACIC SURGEONS PREDICTED RISK OF MORTALITY; TRANSCATHETER AORTIC VALVE IMPLANTATION; VALVE ACADEMIC RESEARCH CONSORTIUM;

AORTIC VALVE STENOSIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MORTALITY; PREDICTIVE VALUE OF TESTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; SOCIETIES, MEDICAL; THORACIC SURGICAL PROCEDURES; TIME FACTORS;

EID: 84885304358     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.01.038     Document Type: Article

References (45)

1. Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement In high-risk patients. N Engl J Med 2011;364:2187-98.
2. Nielsen HH, Klaaborg KE, Nissen H, et al. A prospective, randomised trial of transapical transcatheter aortic valve Implantation vs. surgical aortic valve replacement In operable elderly patients with aortic stenosis: the STACCATO trial. EuroIntervention 2012;8:383-9.
3. Shroyer AL, Coombs LP, Peterson ED, et al. The Society of Thoracic Surgeons: 30-day operative mortality and morbidity risk models. Ann Thorac Surg 2003;75:1856-64 [discussion 1864-5].
4. Leon MB, Piazza N, Nikolsky E, et al. Standardized endpoInt definitions for transcatheter aortic valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium. Eur Heart J 2011;32:205-17.
5. Roques F, Nashef SA, Michel P, et al. Risk factors and outcome In European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardiothorac Surg 1999;15:816-22 [discussion 822-3].
6. Michel P, Roques F, Nashef SA, EuroSCORE Project Group. Logistic or additive EuroSCORE for high-risk patients? Eur J Cardiothorac Surg 2003;23:684-7 [discussion 687].
7. Skipper NC, Matingal J, Zamvar V. Assessment of EuroSCORE In patients undergoing aortic valve replacement. J Card Surg 2011;26:124-9.
8. Ghazy T, Kappert U, Ouda A, Conen D, Matschke K. A question of clinical reliability: observed versus EuroSCORE-predicted mortality after aortic valve replacement. J Heart Valve Dis 2010;19:16-20.
9. Schenk S, Fritzsche D, Atoui R, Koertke H, Koerfer R, Eitz T. EuroSCOREpredicted mortality and surgical judgment for Interventional aortic valve replacement. J Heart Valve Dis 2010;19:5-15.
10. Wendt D, Osswald B, Thielmann M, et al. The EuroSCORE-still helpful In patients undergoing Isolated aortic valve replacement? Interact Cardiovasc Thorac Surg 2010;10:239-44.
11. Ben-Dor I, Gaglia Jr MA, Barbash IM, et al. Comparison between Society of Thoracic Surgeons score and logistic EuroSCORE for predicting mortality In patients referred for transcatheter aortic valve Implantation. Cardiovasc Revasc Med 2011;12:345-9.
12. Généreux P, Head SJ, Van Mieghem NM, et al. Clinical outcomes after transcatheter aortic valve replacement using Valve Academic Research Consortium definitions: a weighted meta-analysis of 3,519 patients from 16 studies. J Am Coll Cardiol 2012;59:2317-26.
13. Barbash IM, Ben-Dor I, Dvir D, et al. Incidence and predictors of acute kidney Injury after transcatheter aortic valve replacement. AmHeart J 2012;163:1031-6.
14. Dager AE, Nuis RJ, Caicedo B, et al. Colombian experience with transcatheter aortic valve Implantation of Medtronic CoreValve. Tex Heart Inst J 2012;39:351-8.
15. Ussia GP, Barbanti M, Petronio AS, et al. Transcatheter aortic valve Implantation: 3-year outcomes of self-expanding CoreValve prosthesis. Eur Heart J 2012;33:969-76.
16. D'Ascenzo F, Moretti C, Salizzoni S, et al. 30 days and midterm outcomes of patients undergoing percutaneous replacement of aortic valve according to their renal function: a multicenter study. Int J Cardiol 2013;167:1514-8.
17. Dehédin B, Guinot PG, Ibrahim H, et al. Anesthesia and perioperative management of patients who undergo transfemoral transcatheter aortic valve Implantation: an observational study of general versus local/regional anesthesia In 125 consecutive patients. J Cardiothorac Vasc Anesth 2011;25:1036-43.
18. Gilard M, Eltchaninoff H, Iung B, et al. Registry of transcatheter aortic-valve Implantation In high-risk patients. N Engl J Med 2012;366:1705-15.
19. Gurvitch R, Toggweiler S, Willson AB, et al. Outcomes and complications of transcatheter aortic valve replacement using a balloon expandable valve according to the Valve Academic Research Consortium (VARC) guidelines. EuroIntervention 2011;7:41-8.
20. Généreux P, Kodali SK, Green P, et al. Incidence and effect of acute kidney Injury after transcatheter aortic valve replacement using the new Valve Academic Research Consortium criteria. Am J Cardiol 2013;111:100-5.
21. Hammerer M, Schuler J, Altenberger J, et al. Rehospitalization rates after transcatheter aortic valve Implantation. Wien KlinWochenschr 2012;124:45-52.
22. D'Onofrio A, Rubino P, Fusari M, et al. Impact of previous cardiac operations on patients undergoing transapical aortic valve Implantation: results from the Italian Registry of Transapical Aortic Valve Implantation. Eur J Cardiothorac Surg 2012;42:480-5.
23. Lange R, Bleiziffer S, Piazza N, et al. Incidence and treatment of procedural cardiovascular complications associated with trans-arterial and trans-apical Interventional aortic valve Implantation In 412 consecutive patients. Eur J Cardiothorac Surg 2011;40:1105-13.
24. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve Implantation for aortic stenosis In patients who cannot undergo surgery. N Engl J Med 2010;363:1597-607.
25. Pilgrim T, Stortecky S, Luterbacher F, Windecker S, Wenaweser P. Transcatheter aortic valve Implantation and bleeding: Incidence, predictors and prognosis. J Thromb Thrombolysis 2013;35:456-62.
26. VanMieghemNM, Tchetche D, Chieffo A, et al. Incidence, predictors, and Implications of access site complicationswith transfemoral transcatheter aortic valve Implantation. Am J Cardiol 2012;110:1361-7.
27. Scherner M, Madershahian N, Rosenkranz S, et al. Transapical aortic valve Implantation: experiences and survival analysis up to three years. J Card Surg 2012;27:653-61.
28. Toggweiler S, Gurvitch R, Leipsic J, et al. Percutaneous aortic valve replacement: vascular outcomes with a fully percutaneous procedure. J Am Coll Cardiol 2012;59:113-8.
29. Wenaweser P, Pilgrim T, Guerios E, et al. Impact of coronary artery disease and percutaneous coronary Intervention on outcomes In patients with severe aortic stenosis undergoing transcatheter aortic valve Implantation. Euro-Intervention 2011;7:541-8.
30. Freeman M, Rodés-Cabau J, Urena M, et al. First-in-man transfemoral transcatheter aortic valve replacement with the 29mm Edwards SAPiEN XT valve. Catheter Cardiovasc Interv Jun 28 2012, http://dx.doi.org/10.1002/ ccd.24543.
31. Himbert D, Pontnau F, Messika-Zeitoun D, et al. Feasibility and outcomes of transcatheter aortic valve Implantation In high-risk patients with stenotic bicuspid aortic valves. Am J Cardiol 2012;110:877-83.
32. D'Onofrio A, Rubino P, Fusari M, et al. Clinical and hemodynamic outcomes of "all-comers" undergoing transapical aortic valve Implantation: results from the Italian Registry of Trans-Apical Aortic Valve Implantation (i-TA). J Thorac Cardiovasc Surg 2011;142:768-75.
33. Buchanan GL, Chieffo A, Montorfano M, et al. The role of sex on VARC outcomes following transcatheter aortic valve Implantation with both Edwards SAPiEN™ and Medtronic CoreValve ReValving System® devices: the Milan registry. EuroIntervention 2011;7:556-63.
34. Mussardo M, Latib A, Chieffo A, et al. Periprocedural and short-term outcomes of transfemoral transcatheter aortic valve Implantation with the SAPiEN XT as compared with the Edwards SAPiEN valve. JACC Cardiovasc Interv 2011;4:743-50.
35. Nuis RJ, van Mieghem NM, van der Boon RM, et al. Effect of experience on results of transcatheter aortic valve Implantation using aMedtronic CoreValve System. Am J Cardiol 2011;107:1824-9.
36. Nuis RJ, Van Mieghem NM, Schultz CJ, et al. Frequency and causes of stroke during or after transcatheter aortic valve Implantation. Am J Cardiol 2012;109:1637-43.
37. Nuis RJ, Dager AE, van der Boon RM, et al. patients with aortic stenosis referred for TAVi: treatment decision, In-hospital outcome and determinants of survival. Neth Heart J 2012;20:16-23.
38. Pilgrim T, Wenaweser P, Meuli F, et al. Clinical outcome of high-risk patients with severe aortic stenosis and reduced left ventricular ejection fraction undergoing medical treatment or TAVi. PLoS One 2011;6:e27556.
39. Stortecky S, Wenaweser P, Diehm N, et al. Percutaneous management of vascular complications In patients undergoing transcatheter aortic valve Implantation. JACC Cardiovasc Interv 2012;5:515-24.
40. Strauch JT, Scherner M, Haldenwang PL, et al. Transapical minimally Invasive aortic valve Implantation and conventional aortic valve replacement In octogenarians. Thorac Cardiovasc Surg 2012;60:335-42.
41. Tamburino C, Barbanti M, Capodanno D, et al. Comparison of complications and outcomes to one year of transcatheter aortic valve Implantation versus surgical aortic valve replacement In patients with severe aortic stenosis. Am J Cardiol 2012;109:1487-93.
42. Ussia GP, Scarabelli M, Mulè M, et al. Dual antiplatelet therapy versus aspirin alone In patients undergoing transcatheter aortic valve Implantation. Am J Cardiol 2011;108:1772-6.
43. van der Boon RM, Nuis RJ, Van Mieghem NM, et al. Clinical outcome following transcatheter aortic valve Implantation In patients with Impaired left ventricular systolic function. Catheter Cardiovasc Interv 2012;79:702-10.
44. Van Mieghem NM, Nuis RJ, Tzikas A, et al. Prevalence and prognostic Implications of baseline anaemia In patients undergoing transcatheter aortic valve Implantation. EuroIntervention 2011;7:184-91.
45. Van Mieghem NM, Généreux P, van der Boon RM, et al. Transcatheter aortic valve replacement and vascular complications definitions. EuroIntervention Sep 27 2012 pii: 20120607-03.